GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » Scaled Net Operating Assets

Touyun Biotech Group (HKSE:01332) Scaled Net Operating Assets : 0.49 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Touyun Biotech Group's operating assets for the quarter that ended in Dec. 2023 was HK$571.3 Mil. Touyun Biotech Group's operating liabilities for the quarter that ended in Dec. 2023 was HK$201.4 Mil. Touyun Biotech Group's Total Assets for the quarter that ended in Jun. 2023 was HK$753.0 Mil. Therefore, Touyun Biotech Group's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.49.


Touyun Biotech Group Scaled Net Operating Assets Historical Data

The historical data trend for Touyun Biotech Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group Scaled Net Operating Assets Chart

Touyun Biotech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.59 0.73 0.52 0.42

Touyun Biotech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.69 0.54 0.59 0.49

Competitive Comparison of Touyun Biotech Group's Scaled Net Operating Assets

For the Packaging & Containers subindustry, Touyun Biotech Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touyun Biotech Group's Scaled Net Operating Assets Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's Scaled Net Operating Assets falls into.



Touyun Biotech Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Touyun Biotech Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(571.304-201.358)/887.697
=0.42

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=607.34 - 36.036
=571.304

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=586.267 - 205.554 - 179.355
=201.358

Touyun Biotech Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2023 )
=(Operating Assets (Q: Dec. 2023 )-Operating Liabilities (Q: Dec. 2023 ))/Total Assets (Q: Jun. 2023 )
=(571.304-201.358)/753.02
=0.49

where

Operating Assets(Q: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=607.34 - 36.036
=571.304

Operating Liabilities(Q: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=586.267 - 205.554 - 179.355
=201.358

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Touyun Biotech Group Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Touyun Biotech Group (HKSE:01332) Business Description

Traded in Other Exchanges
N/A
Address
6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines